Scientists track experimental cancer Pill's journey through the body
NCT ID NCT05109832
Summary
This early-stage study aimed to understand how the body processes a single dose of an experimental cancer drug called IMP4297. Six healthy adult male volunteers took the drug so researchers could track how it was absorbed, broken down, and eliminated. The goal was to gather basic information about the drug's behavior in the human body to help design future cancer treatment studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital of Soochow University
Suzhou, Jiangsu, 215006, China
Conditions
Explore the condition pages connected to this study.